[11C]glycylsarcosine:: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice

被引:23
|
作者
Nabulsi, NB
Smith, DE
Kilbourn, MR [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Radiol, Div Nucl Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
关键词
C-11]glycylsarcosine; Gly-Sar; renal uptake; PepT1; and; PepT2 peptide transporters;
D O I
10.1016/j.bmc.2005.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[C-11]Glycylsarcosine (Gly-Sar) was synthesized as a potential radiotracer to investigate the localization and in vivo function of the peptide transporter PepT2 in mouse kidney. Its C-I 1 labeled diketopiperazine derivative, [C-11]cyclo(Gly-Sar) [1-methylpiperazine-2,5-dione], was also evaluated as a potential tracer. [11C]Gly-Sar exhibited rapid initial uptake into kidneys with slow clearance from the medulla, consistent with uptake and retention of the radiotracer through the actions of PepT2. In contrast, the corresponding cyclized dipeptide [C-11]cyclo(Gly-Sar) showed rapid clearance and accumulation only in the renal pelvis region. Involvement of PepT2 in reabsorption and delayed clearance of [C-11]Gly-Sar was confirmed using the PepT2 knockout mouse, where rapid renal elimination of [C-11]Gly-Sar and the absence of radioactivity in medulla were observed. This study demonstrates using in vivo imaging technique that PepT2 is primarily responsible for renal tubular active reabsorption of Gly-Sar, and provides a new tool for studying tubular peptide reabsorption and clearance. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2993 / 3001
页数:9
相关论文
共 44 条
  • [31] Radiosynthesis of [5-[11C]methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-[5-(tetrahydro-pyran-4-yl)-1,3-dihydro-isoindol-2-yl]-methanone ([11C]RO5013853), a novel PET tracer for the glycine transporter type I (GlyT1)
    Pinard, Emmanuel
    Burner, Serge
    Cueni, Philipp
    Hartung, Thomas
    Norcross, Roger D.
    Schmid, Philipp
    Waldmeier, Pius
    Zielinski, Guy
    Ravert, Hayden T.
    Holt, Daniel P.
    Dannals, Robert F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 (11): : 702 - 707
  • [32] Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[11C]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors
    Christiaans, Johannes A. M.
    Klein, Pieter J.
    Metaxas, Athanasios
    Kooijman, Esther J. M.
    Schuit, Robert C.
    Leysen, Josee E.
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    Windhorst, Albert D.
    NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (08) : 670 - 680
  • [33] Synthesis and Preclinical Evaluation of 2-(2-Furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C}Preladenant) as a PET Tracer for the Imaging of Cerebral Adenosine A2A Receptors
    Zhou, Xiaoyun
    Khanapur, Shivashankar
    Huizing, Anja P.
    Zijlma, Rolf
    Schepers, Marianne
    Dierckx, Rudi A. J. O.
    van Waarde, Aren
    de Vries, Erik F. J.
    Elsinga, Philip H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (21) : 9204 - 9210
  • [34] Synthesis and in vivo evaluation of 6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for Growth Hormone Secretagogue receptor (GHSR)
    Potter, Rachel A.
    Horti, Andrew G.
    Holt, Daniel
    Scheffel, Ursula
    Dannals, Robert F.
    Wahl, Richard L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [35] Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one:: a PET tracer for imaging sigma1 receptors
    Zhang, MR
    Haradahira, T
    Maeda, J
    Okauchi, T
    Kawabe, K
    Kida, T
    Obayashi, S
    Suzuki, K
    Suhara, T
    NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (04) : 469 - 476
  • [36] Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR)
    Potter, Rachel
    Horti, Andrew G.
    Ravert, Hayden T.
    Holt, Daniel P.
    Finley, Paige
    Scheffel, Ursula
    Dannals, Robert F.
    Wahl, Richard L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (07) : 2368 - 2372
  • [37] 123I-MSP and F[11C]MSP:: New selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors.: Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice
    Samnick, S
    Remy, N
    Ametamey, S
    Bader, JB
    Brandau, W
    Kirsch, CM
    LIFE SCIENCES, 1998, 63 (22) : 2001 - 2013
  • [38] Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidinol-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors
    Haradahira, T
    Maeda, J
    Okauchi, T
    Zhang, MR
    Hojo, J
    Kida, T
    Arai, T
    Yamamoto, F
    Sasaki, S
    Maeda, M
    Suzuki, K
    Suhara, T
    NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (05) : 517 - 525
  • [39] Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor
    Hansen, Hanne D.
    Lacivita, Enza
    Di Pilato, Pantaleo
    Herth, Matthias M.
    Lehel, Szabolcs
    Ettrup, Anders
    Andersen, Valdemar L.
    Dyssegaard, Agnete
    De Giorgio, Paola
    Perrone, Roberto
    Berardi, Francesco
    Colabufo, Nicola Antonio
    Niso, Mauro
    Knudsen, Gitte M.
    Leopoldo, Marcello
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 79 : 152 - 163
  • [40] Synthesis, radiosynthesis and in vivo evaluation of 5-[3-(4-benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[11C]one, as a potent NR1A/2B subtype selective NMDA PET radiotracer
    Roger, G
    Lagnel, B
    Besret, L
    Bramoullé, Y
    Coulon, C
    Ottaviani, M
    Kassiou, M
    Bottlaender, M
    Valette, H
    Dollé, F
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (24) : 5401 - 5408